Article Sidebar

Submitted
Jun 25, 2022
Published
Aug 30, 2025
Download
Statistic
Read Counter : 31

Downloads

Download data is not yet available.

Main Article Content

Abstract

COST-FACIT is a financial toxicity measurement instrument that has been validated in several countries. Financial toxicity is a broad term that includes the costs a patient has to bear after a cancer diagnosis, which impacts personal and family budgets. This has implications for increasing awareness of the financial toxicity experienced by cancer patients so that it can support better policies and funding decisions by hospital management and the government. This article is a Narrative Review on studies regarding the influence of COST-FACIT and HRQoL in cancer patients. Search for English articles using the Pubmed, ScienceDirect, and Google Scholar databases, which were published from 2012 to 2022. Based on the Narrative Review that has been done, there are 19 articles that meet the criteria. In the article there are various HRQoL dimensions that are correlated with COST-FACIT. Dimensions that have a moderate to strong influence are psychological (emotional) and financial because the occurrence of financial toxicity can disrupt family expenses every month. If this continues, it can result in psychological distress for the patients and their family.

Keywords

Financial Toxicity HRQoL Dimensions COST-FACIT Influence

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

References

  1. Chan, R. J., GOrdon, L. G., Tan, C. J., Chan, A., Bradford, N. K., Yates, P., Agbejule, O. A., & Miaskowski, C. (2018). Relationships Between Financial Toxicity and Symptom Burden in Cancer Survivors: A Systematic Review. Journal of Pain and Symptom Management, 57(3), 646-660.e1.
  2. Chan, D. N. S., Choi, K. C., Ng, M. S. N., Xing, W., Law, B. M. H., Ho, P.S., Au, C., Chan, M., Tong, M., Ling, W. M., Chan, M., Mak, S. S. S., Chan, R. J., & So, W. K. W. (2021). Translation and Validation of the Traditional Chinese version of the COmprehensive Score for financial Toxicity-Functional Assessment of Chronic Illness Therapy (Version 2). Health Quality of Life Outcomes, 19(1), 17-26.
  3. Dar, M. A., Chauhan, R., Sharma, K. K., Trivedi, V., Dhingra, S., and Murti, K. (2021). Assessing the Reliability and Validity of Comprehensive Score for Financial Toxicity (COST) among radiation Oncology Patients in India: a Cross-Sectional Pilot Study. ecancermedicalscience, 15, 1219-1232.
  4. de Souza, J. A, Yap, B. J., Wroblewski, K., Blinder, V., Araȗjo, F. S., Hlubocky, F. J., Nicholas, L. H., O’Connor, J. M., Brockstein, B., Ratain, M. J., Daugherty, C. K., & Cella, D. (2017). Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer, 123(3), 476-484.
  5. D'Rummo, K. A., Nganga, D., Chollet-Hinton, L., and Shen, X. (2022) Comparison of Two Validated Instruments to Measure Financial Hardship in Cancer Survivors: Comprehensive Score for Financial Toxicity (COST) versus Personal Financial Wellness (PFW) Scale. Support Care Centre, 31(1), 12-27.
  6. Durber, K., Halkett, G. K. B., McMullen, M., and Nowak, A. K. (2021). Measuring financial toxicity in Australian cancer patients – Validation of the COmprehensive Score for financial Toxicity (FACT COST) Measuring Financial Toxicity in Australian Cancer Patients. Asia-Pacific Journal of Clinical Oncology, 17(4), 377-387.
  7. Honda, K., Gyawali, B., Ando, M., Kumanishi, R., Kato, K., Sugiyama, K., Mitani, S., Masuishi, T., Narita, Y., Bando, H., Taniguchi, H., Kadowaki, S., Ura, T., and Muro, K. (2019). Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer. Journal of Global Oncology, 5, 1-8.
  8. Joshi A, Kalra D, Menin N, et al. (2022). Translation and Validation of COST - FACIT (Version 2) Questionnaire into Hindi and Marathi to Assess Financial Toxicity in Indian Cancer Patients. South Asian Jounal of Cancer, 11(2), 97-104.
  9. Lentz, R., Benson III, Al. B., and Kircher, S. (2019). Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies. Journal of Surgical Oncology, 120(1), 85-92.
  10. Nogueira, L. de A., Lenhani, B. E., Tomim, D. A., and Kalinke, L. P. (2020a). Financial Toxicity. Asian Pacific Journal of Cancer Prevention, 21(2), 289-293.
  11. Nogueira, L. de A., Koller, F. J., Marcondes, L., Mantovani, M. de F., Marcon, S. S., Guimarães, P. R. B., and Kalinke, L. P. (2020b). Validation of The Comprehensive Score for Financial Toxicity for Brazilian Culture. ecancermedicalscience, 14, 1158.
  12. Pavela, G., Fifolt, M., Tison, S. E., Allison, M., Burton, B. S., and Ford, E. W. (2020). Re-Validation of the COmprehensive Score for Financial Toxicity (COST): Assessing the Scale’s Utility in Chronic Disease Populations. Health Services Insights, 14, 11786329211057352.
  13. Ripamonti, C. I., Chiesi, F., Di Pede, P., Guglielmo, M., Toffolatti, L., Gangeri, L., and Allocca, E.(2020). The Validation of the Italian Version of the COmprehensive Score for Financial Toxicity (COST). Support Care Cancer, 28(9), 4477–85.
  14. Sharif, S.P., Sim, O. F., and Moshtagh, M. (2020). Psychometric Evaluation of the Comprehensive Score for Financial Toxicity Scale Among Iranian Cancer Patients. Journal of Cancer Policy, 30, 100308.
  15. Shim, S. Kang, D., Kim, N., Han, G., Lim, J., Kim, H., Park, J., Lee, M., Lee, J. E., Kim, S. W., Yu, J., Chae, B. J., Ryu, J. M., Nam, S. J., Lee, S. K., and Cho, J. (2021). Validation of Korean Version of the COmprehensive Score for Financial Toxicity (COST) among Breast Cancer Survivor. Cancer Research and Treatment, 54(3), 834-841.
  16. Xu, T., Xu, L., Xi, H., Zhang, Y, Zhou, Y, Chang, N, Yang, W., Zhang, Y., Wang, M., Ju, Q., Yang, X., Chen, X., Che, Y., Chen, F, Qu, S, and Zhang, Z. (2022). Assessment of Financial Toxicity Among Patients With Advanced Lung Cancer in Western China. Front Public Health, 9, 754199.
  17. Yu, H-H., Yu, Z. F., Li, H., Zhao, H., SUn, J-M., and Liui Y-Y. (2021). The COmprehensive Score for financial Toxicity in China: Validation and Responsiveness. Journal of Pain and Symptom Management, 61(6), 1297-1304.e1.
  18. Yusof, K. Md., Mahmud, R., Abdullah, M., Avery-Kiejdam, K. A., and Roslim, R. (2021). Cross-Cultural Adaptation of the Functional Assessment of Cancer Therapy-Breast (FACT-B) in Malaysian Breast Cancer Survivors. Asian Pacific Journal of Cancer Prevention. 22(4), 1055-1061.
  19. World Health Organization (2020). Cancer facts Sheets in Indonesia. Available from: https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf. [Accessed April 7th, 2022].